MMED — Minimed Cashflow Statement
0.000.00%
Last trade - 00:00- $4.00bn
- $4.00bn
- $3.10bn
Annual cashflow statement for Minimed, fiscal year end - April 24th, USD millions except per share, conversion factor applied.
2023 April 28th | 2024 April 26th | 2026 April 24th | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | — |
| Source: | PROSPECTUS | PROSPECTUS | |
| Standards: | USG | USG | — |
| Status: | Final | Final | fx Preliminary |
| Net Income/Starting Line | -92 | -107 | — |
| Depreciation | |||
| Deferred Taxes | |||
| Non-Cash Items | 74 | 89 | — |
| Other Non-Cash Items | |||
| Changes in Working Capital | -92 | -73 | — |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Payable / Accrued Expenses | |||
| Net Change in Other Assets & Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -6 | 41 | — |
| Capital Expenditures | -167 | -148 | — |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -13 | -9 | — |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -180 | -157 | — |
| Financing Cash Flow Items | 185 | 112 | — |
| Other Financing Cash Flow | |||
| Cash from Financing Activities | 185 | 112 | — |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -1 | -4 | — |